Weight Loss Programs in Santa Barbara

If you’ve struggled to lose weight with diet and exercise alone, you’re not alone. At MiraMed, we offer medically supervised weight loss programs using the latest FDA-approved medications that have revolutionized weight management.

Our programs feature Semaglutide (the active ingredient in Ozempic and Wegovy) and Tirzepatide (Mounjaro) – medications that have shown remarkable results in clinical trials. These GLP-1 receptor agonists work with your body’s natural systems to reduce appetite, increase feelings of fullness, and help you lose weight effectively.

Under the supervision of Dr. Hetal Patel, MD, our weight loss program is personalized to your health profile, goals, and lifestyle. We provide ongoing support, regular check-ins, and dosage adjustments to optimize your results.

This isn’t a quick fix or fad diet – it’s a comprehensive, medically-supervised approach to achieving and maintaining a healthy weight.

Medical weight loss visits at MiraMed typically take 30 minutes for the initial consultation and about 15 minutes for monthly follow-ups, which cover progress, side effects, and any dose adjustments. There is no downtime in the traditional sense – Zepbound (tirzepatide) by Eli Lilly and Wegovy (semaglutide) by Novo Nordisk may cause side effects such as nausea, constipation, or abdominal discomfort, particularly when starting treatment or increasing the dose, and an anti-nausea medication can be prescribed when appropriate.

Good candidates are generally adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related medical condition. Patients with a lower BMI who are experiencing persistent difficulty losing weight, including some patients undergoing hormone replacement therapy, may be considered on an individual basis after provider evaluation of their health history, labs, goals, and overall risk-benefit profile.